Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Protease Inhibitors in AIDS-Related Kaposi's Sarcoma
NCT00003008Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Dec 1997
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of paclitaxel in Kaposi sarcoma (KS) (2 arms), sponsored by Eastern Cooperative Oncology Group. Primary endpoints: Plasma Clearance of Paclitaxel at Day 1 and Body Distribution of Paclitaxel at Day 1. Started Dec 1997; status: completed.
02
Drugs
paclitaxel
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT00003008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003008.